EU agency recommends Roche drug for type of ovarian cancer
ZURICH (Reuters) - Roche said on Friday that European regulators had recommended approval of its drug Avastin as a treatment for women with ovarian cancer that is resistant to platinum-containing chemotherapy.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Avastin | Cancer | Cancer & Oncology | Chemotherapy | Health | Ovarian Cancer | Ovaries | Women